OpenURL Connection Search

Select item for more details and to access through your institution.

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Published in:
European Journal of Neurology, 2014, v. 21, n. 1, p. 40, doi. 10.1111/ene.12204
By:
- Outteryck, O.;
- Ongagna, J.C.;
- Brochet, B.;
- Rumbach, L.;
- Lebrun‐Frenay, C.;
- Debouverie, M.;
- Zéphir, H.;
- Ouallet, J.C.;
- Berger, E.;
- Cohen, M.;
- Pittion, S.;
- Laplaud, D.;
- Wiertlewski, S.;
- Cabre, P.;
- Pelletier, J.;
- Rico, A.;
- Defer, G.;
- Derache, N.;
- Camu, W.;
- Thouvenot, E.
Publication type:
Article
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis.
Published in:
Journal of Neurology, 2021, v. 268, n. 2, p. 669, doi. 10.1007/s00415-020-10154-5
By:
- Lejeune, F.;
- Chatton, A.;
- Laplaud, D.-A.;
- Le Page, E.;
- Wiertlewski, S.;
- Edan, G.;
- Kerbrat, A.;
- Veillard, D.;
- Hamonic, S.;
- Jousset, N.;
- Le Frère, F.;
- Ouallet, J.-C.;
- Brochet, B.;
- Ruet, A.;
- Foucher, Y.;
- Michel, Laure
Publication type:
Article
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.
Published in:
Journal of Neurology, 2018, v. 265, n. 10, p. 2251, doi. 10.1007/s00415-018-8984-7
By:
- On behalf of the Société Francophone de la Sclérose en Plaques;
- Michel, L.;
- Lefrere, F.;
- Laplaud, D. A.;
- Derkinderen, P.;
- Wiertlewski, S.;
- Balloy, G.;
- Lejeune, P.;
- Devos, P.;
- N'Kendjuo, J.-B.;
- Coustans, M.;
- Auffray-Calvier, E.;
- Daumas-Duport, B.;
- Brosset, C.;
- de Seze, J.;
- Pelletier, J.;
- Suchet, L.;
- Lebrun, C.;
- Cohen, M.;
- Vermersch, P.
Publication type:
Article
Response to Finsterer and colleagues on 'Prospective studies on the efficacy of rituximab for myasthenia gravis are warranted'.
Published in:
European Journal of Neurology, 2020, v. 27, n. 12, p. e94, doi. 10.1111/ene.14460
By:
- Dos Santos, A.;
- Pereon, Y.;
- Wiertlewski, S.;
- Magot, A.
Publication type:
Article
Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real‐life study.
Published in:
European Journal of Neurology, 2020, v. 27, n. 11, p. 2277, doi. 10.1111/ene.14391
By:
- Dos Santos, A.;
- Noury, J. ‐B.;
- Genestet, S.;
- Nadaj‐Pakleza, A.;
- Cassereau, J.;
- Baron, C.;
- Videt, D.;
- Michel, L.;
- Pereon, Y.;
- Wiertlewski, S.;
- Magot, A.
Publication type:
Article
T cell repertoire analysis and comparison between different compartments in two MS patients.
Published in:
2010
By:
- Salou, M.;
- Michel, L.;
- Garcia, A.;
- Elong-Ngono, A.;
- Wiertlewski, S.;
- Soulillou, J. P.;
- Brouard, S.;
- Laplaud, D. A.
Publication type:
Abstract

Found: 6

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.

SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis.

Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.

Response to Finsterer and colleagues on 'Prospective studies on the efficacy of rituximab for myasthenia gravis are warranted'.

Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real‐life study.

T cell repertoire analysis and comparison between different compartments in two MS patients.